This review explores mechanisms of melanocyte loss in vitiligo, indicating the significance of psychological impacts and therapeutic strategies.
Vitiligo is a chronic skin disorder characterized by the loss of melanocytes, leading to depigmented white patches on the skin. The disease affects approximately 1–2% of the global population and can occur at any age. Although vitiligo does not directly threaten life, it has significant psychological and social impacts. The aim of this article is to review the etiology, clinical manifestations, pathogenesis, and modern treatment approaches of vitiligo. Understanding the mechanisms of melanocyte destruction and immune dysregulation is essential for improving diagnostic and therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Axmedov et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: